We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cambridge Nutritional Sciences Plc | LSE:CNSL | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.35 | 4.20 | 4.50 | 4.35 | 4.35 | 4.35 | 335,151 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices-holdng Companies,nec | 8.19M | -3.86M | -0.0162 | -2.69 | 10.34M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/4/2024 16:25 | Late buyers - interesting !!!! | silverspoon2009 | |
26/4/2024 16:13 | Late in the day but possibly the last chance to get any sub 3.9p, that 250k buy has taken the overhang away, now just 100k shares on offer. The shares are very well supported around current levels on the book. Through 4p and 6p comes into play quite quickly. | broken_arrow1 | |
25/4/2024 08:51 | Gentlemen The Gracious Fellow has received a number of requests from followers for an update following recent outstanding numbers. The matter is simple, hold onto your shares for dear life, what is clearly evident is the company is going about it's business, not shouting from the rooftops but enhancing shareholder value in droves. Re-iterate the view that CNSL remains a outstanding opportunity with a near term valuation metric many multiples ahead of £9m. The shares are a buy plain and simple. Hope that helps. | yasxii | |
25/4/2024 07:03 | Scam of a company mark my words! | revbessex | |
24/4/2024 12:01 | Impossible to buy in any reasonable size currently, limit order placed, we will see if it gets filled. Yesterdays update means the stock is well under par from a value perspective. No wonder it is hard to buy. I see this heading to a £20m+ m/cap, double current levels. | silverspoon2009 | |
24/4/2024 08:10 | Very little stock around early doors, a number of platforms are 'at best' and IG are asking a premium for modest size. It looks like being a good day again for holders. | broken_arrow1 | |
23/4/2024 15:59 | Yes still a long way to go, the last broker target price, this was before yesterdays excellent update which beat market expectations. The stock is miss priced by multiples - 12p a share target. multiples. | thecoyone | |
23/4/2024 15:34 | Nice...but still a long way to go. | rivaldo | |
23/4/2024 14:22 | Remember the City Boys have to take their fill of shares before it will be allowed to rise strongly. The top of the class Trading Update yesterday caught many by surprise. You need to know the game. Is it a stonking buy ? - It looks like it ;-) | wealth_creator | |
23/4/2024 14:13 | There is a chart breakout. | kingston78 | |
23/4/2024 10:17 | I am adding more shares to my portfolio. This share is a winner. | kingston78 | |
23/4/2024 08:51 | Book continues to strengthen behind the scenes, most platforms are 'at best' on any size to buy. | broken_arrow1 | |
23/4/2024 08:24 | Wbodger I agree with what you say, my fear is the company will be acquired for a fraction of true value. As you suggest buying this stock at current levels is like buying a £10 note for £5 and that is a conservative example. Having followed a number of relatively illiquid juniors I have noticed a re-rate usually comes when the dust from news settles. I think this will occur here. So far I have not seen any media channels or PR promoting from the usual suspects I think Justin Waite from Vox Markets promoted the company as undervalued a few months back. It is only a matter of time before a promote channel latches on, this will bring much needed volume, Zak Mir also has this on his radar as he has charted it a few times. I still think the shares will be 10p+ by year end. | thecoyone | |
23/4/2024 08:11 | A number of platforms are 'at best' on any size this morning, the market is asking a large premium for size. The wide spread tells you they are struggling for stock, the free float appears small. It will be interesting to see how the market makers play it, a few buys and it will break through 4p and then we have a significant breakout with 6p on the cards. | broken_arrow1 | |
23/4/2024 07:59 | I have taken the view that the company broker Cavendish are quite useless, something I will mention to management at the next online event. Cavendish have no excuses now to offer a target price, something that has been missing for over 6 months. It is very clear Cavendish are very bullish of this company, and why not, however they have made no real attempt to try to re-value it. It is obvious that a company expanding in a growth market like Health & Nutrition should have a EV of more than £4m, the cash position being £5.4m v the m/cap of £9m. My view is they should, at the very least, re-iterate their previous target price of 12p a share. At current levels the shares are a no brainer buy. | thecoyone | |
22/4/2024 21:56 | Understandable they want a premium for 150,000 shares - CNSL could be a bid target and there are only 237 million shares in issue. I'm surprised there is any market at 3.7p at all, mid price, because that only equates to a £9 million market cap. That's derisory. If Cavendish can't get the share price higher shame on them. The LSE is in trouble because financial advisors and Nomads get paid for getting companies sold at stupid prices. That's the clear danger here - lowball takeover. Companies that don't buy back their own shares when they are under shorting attack get taken over for peanuts. CNSL has cash, if their advisor thinks market cap should be £23 million use some of the cash to buy back shares. That's what I do if I can buy £10 notes for a fiver. | wbodger | |
22/4/2024 15:50 | Book is strengthening now asking a premium for 150k+ of shares. | broken_arrow1 | |
22/4/2024 14:39 | Broker Cavendish are very impressed with today's statement, their target price, the last one implied the H&N business was worth around 10p a share, is under review. From today.... | thecoyone | |
22/4/2024 14:30 | They would have you believe there are plenty of shares free to buy, there are not, a premium being asked already for size despite the wide spread. Over the next few sessions I can see the share price breaking and holding above 4p with the next move 5p+ | broken_arrow1 | |
22/4/2024 13:25 | All positive numbers. You don't find many companies reporting such as positive trading statement. The company will grow on its own, or be taken over by a larger group. Either way, I am a happy shareholder. | kingston78 | |
22/4/2024 12:21 | My understanding is it is being strongly contested and CNSL have also put in what they describe as a very significant counter claim. CNSL legal advice implies they have no liability to repay it, on the contrary in fact. The Gov have not been responding to CNSL so that in itself is a sign they (the Gov) are potentially liable to pay damages, I have followed this matter extensively. So far the new team at CNSL have hardly put a foot out of place. | thecoyone | |
22/4/2024 12:09 | What happened to the repayment of the £2million government loan for Covid testing equipment? | mdw1 | |
22/4/2024 11:25 | A very encouraging trading statement, and way ahead of Cavendish's expectations: - £9.8m revenues compared to £9.0 forecast - £5.4m cash pile compared to £4.2m forecast - gross profit of over £6m compared to £5.6m forecast - positive EBITDA compared to break-even forecast Plus this year "has started well with good momentum going into the first quarter with a healthy order book". Pretty good for a £9.1m m/cap company at 3.85p | rivaldo | |
22/4/2024 09:51 | Takeover target IMO. | space_dust | |
22/4/2024 09:47 | Still can't buy a stitch online and no wonder given todays update. How many AIM Co's exceed market expectations, profitable, have £5.5m in the bank and are only valued under £9m. Can't think of many. | one2go |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions